The vascular system is the body’s essential infrastructure for regeneration—delivering oxygen, nutrients, and signaling cues that coordinate tissue repair. Over time, however, this regenerative ...

Nature has consistently inspired engineering applications. Recently, a group of researchers drew new inspirations from the vascular network and developed a new type of fluidic system named VasFluidics ...

The FDA granted a Priority Review in February 2024 and was assigned a PDUFA date of August 10, 2024. ATEV is a bioengineered human tissue designed to be a universally implantable vascular conduit for ...

Steatotic liver disease (commonly called fatty liver disease) progresses silently. Even in the absence of noticeable symptoms ...

When biomedical researchers need to test their latest ideas, they often turn to engineered human tissue that mimics the responses in our own bodies. It's become an important intermediary step before ...

Vascular stents, which consist of a metal structure and a polymer covering, play a critical therapeutic role in cardiovascular treatment. The polymer acts as a physical barrier between blood and the ...

The study reframes neuropathy as a key determinant of tissue recovery rather than an irreversible endpoint. BREA, Calif., Jan. 21, 2026 /PRNewswire/ -- Rapid Nexus Nanotech Wound Solutions, Inc., a ...

On Thursday, the FDA granted full approval to Humacyte, Inc.’s (NASDAQ:HUMA) Symvess (acellular tissue-engineered vessel-tyod) use in adults as a vascular conduit for extremity arterial injury when ...

DURHAM, N.C., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (HUMA), a biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today ...

An investigational product called Acellular Tissue Engineered Vessel demonstrated superior hemodialysis vascular access outcomes compared with AVFs in a phase 3 trial. A bioengineered human tissue ...